← All trials
NCT06813898
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 17, 2025
- Primary completion
- Feb 1, 2027
- Completion date
- Feb 1, 2032
- First posted
- Feb 7, 2025
- Last posted
- Feb 18, 2025
- Enrollment
- 27
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Northwestern UniversityLead sponsor
- Northwestern UniversityOfficial
- National Cancer Institute (NCI)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.